Skip to main content (Press Enter).
Toggle navigation
JPEO-CBRND
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
JPEO-CBRND
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Search
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Home
Our Story
Leadership
About
Joint Project Managers & Joint Project Leads
Media
News
Photography
Work With Us
SPARK
Careers
Resources
Coronavirus
Contact
NEWS
| May 14, 2021
JPM CBRN Medical’s RAIDR RF Innovates DOD Medical Acquisition, Wins BRONZE at 2021 Edison Awards
By Erik Heine, JPM CBRN Medical Strategic Communications
The annual Edison Awards competition is dedicated to honoring excellence and showcasing game-changing innovations that are rapidly reshaping the evolving world around us. An Edison Award recognition is one of the highest accolades an organization can receive, and the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) proudly brought home a 2021 Edison Award BRONZE win in the category of “Innovative Services, Prescription Drug Access Platforms” with its
Rapid Acquisition and Investigation of Drugs for Repurposing (RAIDR) Repurposing Framework (RF)
.
The JPM CBRN Medical organization is committed to providing U.S. military forces and the nation with safe, effective, and innovative medical solutions to counter chemical, biological, radiological, and nuclear (CBRN) threats. It also facilitates the advanced development and acquisition of medical countermeasures (MCMs) and systems to enhance the nation’s biodefense response capability. To this end, the
RAIDR RF
was born, a comprehensive process that facilitates the rapid delivery of an existing MCM to both the warfighter and the general population like never before. Conceived and created by a group of regulatory, quality, logistics, strategic, scientific, and legal subject matter experts, the
RAIDR RF
is an innovative way of assessing existing medical technology for expanded benefit. The
RAIDR RF
process utilizes several tools – to include a Repurposing Scorecard and a Repurposing Report - that, when effectively used together, have proven capable of successfully identifying the likelihood that an MCM will make a promising repurposing candidate.
In the world of drug development, traditional processes in the United States can easily take over a decade, and cost billions of dollars to travel from a laboratory to your medicine cabinet. But in the face of, say, a pandemic like COVID-19, people do not have that kind of time; and the value of the JPM CBRN Medical’s
RAIDR RF
has proven itself under fire. During the current pandemic, over 33 compounds have already been reviewed using this process; this has resulted in 11 successful “deliveries” to end users (defined as products in the hands of the people that need them) and 12 National Stock Numbers (NSN) assignments. The
RAIDR RF
process has made it possible to provide key medical interventions much more quickly than standard development and acquisition, without compromising safety, efficacy, or quality; and all at a fraction of the cost. Repurposed drugs are also more sustainable, as they are already in production, with existing manufacturing infrastructures and supply chains.
“The
RAIDR RF
holds great promise for outbreak and pandemic applications, and even broader application for future CBRN threats”, said U.S. Army Col. Ryan Eckmeier, Joint Project Manager for CBRN Medical. “We are proud to receive the BRONZE Edison Award for ‘Innovative Services, Prescription Drug Access Platforms,’ and look forward to providing additional benefit to our service members and the nation through accelerated delivery of safe and effective medical countermeasures, using this framework.”
For more information about the
RAIDR RF
, visit:
https://www.jpeocbrnd.osd.mil/JPM-CBRN-Medical-RAIDR/
SHARE
PRINT
JPM CBRN Medical
News Search
News Archive - Search by Year and Month
May 2022 (1)
March 2022 (2)
February 2022 (2)
January 2022 (5)
December 2021 (1)
November 2021 (6)
October 2021 (2)
September 2021 (1)
July 2021 (1)
June 2021 (1)
May 2021 (8)
April 2021 (6)
March 2021 (2)
February 2021 (5)
January 2021 (4)
December 2020 (3)
November 2020 (1)
August 2020 (1)
July 2020 (3)
May 2020 (1)
April 2020 (1)
March 2020 (4)
February 2020 (1)
December 2019 (2)
November 2019 (2)
October 2019 (2)
September 2019 (2)
March 2019 (1)
January 2019 (2)
December 2018 (1)
October 2018 (1)
July 2018 (1)
April 2018 (1)
February 2018 (1)
December 2017 (1)
November 2017 (2)
September 2017 (1)
June 2017 (2)
January 2017 (3)
December 2016 (1)
JPEO-CBRND Press Kit
Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.
JPEO-CBRND Public Affairs Office
The JPEO-CBRND Communications Affairs Network coordinates and responds to all Public Affairs needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.